Get started
Work

Supplementary Table 3 from Proteomic Characterization of Breast Cancer Xenografts Identifies Early and Late Bevacizumab-Induced Responses and Predicts Effective Drug Combinations

Year: 2023
Type: supplementary-materials
Abstract: PDF file - 37K, Supplementary Table 3: Protein regulation in basal‐like tumors after bevacizumab and BEZ235 treatment.
DOI: 10.1158/1078-0432.22450134
Authors: Evita M. Lindholm, Marit Krohn, Sergio Iadevaia, Alexandr Kristian, Gordon B. Mills, Gunhild M. Mælandsmo, Olav Engebraaten
Language: English
Subfield: Cancer Research
Open Access status: gold
OpenAlex ID: W4361907913
Cites:
Cited by:
Related to: 10